Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Obesity

Weight-loss jabs may create a new kind of yo-yo dieting

For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Mounjaro, whose active ingredient is tirzepatide, also acts on…

The Conversation

Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase

Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients. Awiqli aims to reduce barriers to insulin initiation, which is often delayed in India. The Indian insulin market is projected to grow significantly in…

The Economic Times

Obesity drugs bring weight loss but not better quality of life, study finds

Obesity drugs are growing in popularity worldwide, but a new study has found that, beyond the weight-loss results, most of these medications do not bring broader quality-of-life benefits after one year of use.

Euronews

From analysis to the latest developments in health,
read the most diverse news in one place.

Study finds most weight loss drugs including Wegovy and Mounjaro ‘do not improve quality of life’

Wegovy pills found to have less positive impact on heart health than injectable counterparts

The Independent UK

Mental illness is up in young people, dementia is now the biggest killer: Australia’s health in 2026

Australians’ life expectancy has increased steadily over time but dropped during the COVID pandemic, according to a new report released today by the Australian Institute of Health and Welfare.

The Conversation

America gets supersized as obesity rates spike in both children and adults

Rising obesity rates have been tied to a more sedentary lifestyle and ultraprocessed diet

The Independent UK

Men’s average testosterone levels have halved in last 50 years, say scientists

Exclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

A New FDA-Approved Oral Weight Loss Pill Requires No Fasting: What Makes Foundayo Different from Other GLP-1 Drugs

FDA approved Foundayo (orforglipron) on April 1, 2026 — the only oral GLP-1 pill for weight loss you can take any time of day without fasting. Average weight loss: 12.4%. Here's the breakdown.

Medical Daily

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner

Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.

MarketBeat

5 Days into the Medicare GLP-1 Bridge, Many Eligible Seniors Are Still Being Denied at the Pharmacy

Medicare GLP-1 Bridge launched July 1. Eligible seniors are getting rejected because pharmacies may submit claims wrong. Here's the specific fix to get your prescription filled.

Medical Daily

Air pollution may cause childhood obesity by disrupting impulse control, study finds

Babies exposed to higher levels of neurotoxin more likely to have difficulty controlling impulses later, research shows

The Guardian - US

PCOS and Cardiovascular Risk: What Your Hormonal Diagnosis Means for Your Heart

The cardiac risk nobody mentions at diagnosisWhen a gynaecologist confirms PCOS, the conversation almost always centres on irregular periods, weight, or fertility. The heart rarely comes up. A 2023 meta-analysis published in the European Heart Journal, covering data from over 900,000 women, found that those with PCOS face a 30…

Times Life

7 Signs of Low Testosterone That Indian Men Routinely Mistake for Normal Aging Symptoms

The Tiredness That Sleep Cannot FixMost men notice it first as an energy problem. They sleep seven or eight hours and wake up feeling like they haven't slept at all. Afternoon crashes arrive earlier. The motivation to get through the evening disappears by 7 PM. This gets filed under stress,…

Times Life

Food Processing Minister Chirag Paswan asks food cos to focus on making quality products

Union Minister Chirag Paswan underscored the potential within India's food processing industry, encouraging businesses to focus on quality to compete in international markets. He raised alarms about the increasing obesity rates among young people, advocating for healthier snack options.

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Women Are Getting Hired More After Losing Weight on GLP-1 Drugs: A New Study Raises Difficult Questions

A new study found GLP-1 drug users hired more after weight loss — but researchers say the finding reflects illegal-in-most-states weight discrimination, not just health gains.

Medical Daily

Scientists Just Found Why Middle-Age Belly Fat Suddenly Appears, and It Has to Do with Stem Cells

New research published June 27 found aging-activated stem cells drive middle-age belly fat accumulation. The same visceral fat is linked to heart disease and Alzheimer's risk.

Fit & Well

“GLP-1s are changing obesity care, but they’ve also created unrealistic expectations”—the CEO of the American Council on Exercise on common weight loss misconceptions

Treating GLP-1s as a substitute for lifestyle change is one of the most common mistakes people make, says this industry expert

Medical Daily

Medicare's New $50 GLP-1 Weight-Loss Program Just Launched: Find Out if You Qualify

Medicare's GLP-1 Bridge launched July 1, 2026. Up to 3.8M seniors may qualify for $50/month Wegovy, Zepbound, or Foundayo. Here's the eligibility breakdown.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Obese adults heart attack risk now similar to slim people thanks to widespread use of statins, study finds

Statins, a cholesterol lowering drug taken by about 8 million people in the UK, could be narrowing the heart attack risk between obese adults and those of a healthy weight

Medical Daily

Four GLP-1 Findings from June 2026 Are Changing the Picture of What These Drugs Actually Do

Four GLP-1 studies published in June 2026 show effects on breast cancer, violence, bone fractures, and physical activity. Here's what each found and what it means for patients.

The Conversation

New obesity figures highlight the income divide

The number of obese adults in England rose from 26% in 2019 to 30% in 2025, according to a new analysis of 55 million people. Nearly one in three adults are now obese.

The Guardian - UK

About 170,000 people in England expected to die from obesity-linked heart conditions by 2035

British Heart Foundation finds about 45 people a day expected to die over next decade if current trends continue

The Economic Times

Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like long-term adherence and physician conservatism. Biocon's Kiran Mazumdar-Shaw weighed in and urged caution, emphasizing diet and exercise as primary options for non-diabetic, non-obese individuals, citing potential long-term side effects of these…

International Business Times UK

Grim Autopsy Details Torture As Morbidly Obese Seven-Year-Old Boy Weighing More Than Two Grown Men Suffers Fatal Agony

A Michigan couple faces murder and child abuse charges after their seven-year-old son died from heart failure linked to extreme obesity, highlighting severe neglect and household dysfunction.

The Economic Times

'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugs

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges with weekly injections and conservative doctor prescribing habits as key hurdles. The advent of oral alternatives might boost uptake, suggesting convenience and long-term commitment, rather than price, will drive future acceptance of…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Australian Research Council

Imperial College London

the National Health and Medical Research Council

119 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.